isa-720
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2005 (NCT01081847)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- isa720
- isa 720
- isa-720
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06414733 | Phase 1 | Nov 1, 2024 | Indiana University |
| NCT02743455 | Phase 1 | Jul 5, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01376505 | Phase 1 | Jun 1, 2011 | Ohio State University |
| NCT00487916 | Phase 1 | Jun 13, 2007 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01081847 | Phase 1 | Jul 1, 2005 | Malaria Vaccine and Drug Development Center |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2007 |
| Indiana University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Malaria Vaccine and Drug Development Center | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Ohio State University | Academic/Hospital | 1 | 1 | 1 | 2011 |
4 organizations
Page 1 / 1